Published in Actas Urol Esp on January 01, 1997
[Variability of rectal examination of the prostate among various groups of observers]. Actas Urol Esp (1997) 1.40
[Giant bizarre scrotal leiomyoma]. Arch Esp Urol (2004) 0.86
[Treatment with sildenafil of cold glands syndrome after inflatable penile prosthesis]. Actas Urol Esp (2004) 0.84
[Morbidity of and tolerance to ultrasonography-guided transrectal biopsy of the prostate]. Actas Urol Esp (1997) 0.84
[Initial treatment of pyonephrosis using percutaneous nephrostomy. Value of the technique]. Arch Esp Urol (1993) 0.82
[Non-specific granulomatous prostatitis diagnosed with ultrasonography-guided transrectal biopsy]. Actas Urol Esp (1998) 0.82
[Nutcracker's syndrome: demostration with helicoidal TC with volumetric reconstruction "3D"]. Actas Urol Esp (2004) 0.80
[Localized prostate cancer treatment in renal transplant patient with high intensity focalized ultrasound (HIFU)]. Actas Urol Esp (2005) 0.79
[Subcapsular renal hematoma following shock wave lithotripsy]. Arch Esp Urol (1995) 0.78
Bladder cancer in Spain 2011: population based study. J Urol (2013) 0.78
[Myofibroblastic tumor of bladder]. Actas Urol Esp (2005) 0.78
[Volume determinations of the whole prostate and of the adenoma by transrectal ultrasound: correlation with surgical specimen]. Actas Urol Esp (2006) 0.78
Traumatic rupture of horseshoe kidney. Urol Int (2011) 0.77
[Primary seminal vesicle abscess: diagnosis and treatment by transrectal ultrasound]. Actas Urol Esp (2005) 0.76
[Incidental prostatic cancer]. Actas Urol Esp (2000) 0.76
[Efficacy and safety of two dosing regimens with Tadalafil in Spanish men with erectile dysfunction: results from the SURE study in 14 European countries]. Actas Urol Esp (2006) 0.76
[Usefulness++ of total parenteral nutrition in radical surgery for bladder cancer]. Actas Urol Esp (1992) 0.76
[Diagnostic imaging of intrahepatic lesions]. An Med Interna (1998) 0.75
[Prolactin and cancer of the prostate. IV. Prolactin inhibition in the treatment of prostatic cancer]. Arch Esp Urol (1983) 0.75
[Mechanical preparation of the intestine with a 10 percent mannitol solution in radical surgery of the bladder]. Arch Esp Urol (1990) 0.75
[Retroperitoneal laparoscopic nephrectomy: a case report]. Actas Urol Esp (1994) 0.75
[Clinical and ultrasonographic characteristics of prostatic cancer diagnosed with transrectal biopsy]. Arch Esp Urol (1999) 0.75
[Prostate cancer in the transition zone in sympatomatic patients with no rectal signs and negative peripheral zone biopsy]. Arch Esp Urol (1998) 0.75
[The diagnostic effectiveness of repeat echo-guided transrectal biopsy as a function of the clinical and anatomicopathological findings]. Actas Urol Esp (1999) 0.75
[Necrotizing vasculitis located exclusively in the bladder: report of a case]. Actas Urol Esp (1994) 0.75
[Echo-Doppler duplex combined with intracavernous injection of prostaglandin E1 in the diagnosis of impotence]. Arch Esp Urol (1992) 0.75
[Primary hyperthyroidism and lithiasis]. Actas Urol Esp (1985) 0.75
[A new surgical technic as a substitute for orchiectomy in the treatment of prostate cancer]. Actas Urol Esp (1983) 0.75
[Polyorchidism: review and contribution of a new case]. Actas Urol Esp (1986) 0.75
[Sponge kidney and lithiasis]. Actas Urol Esp (1983) 0.75
[Cystic carcinoma of the prostate. Echographic diagnosis]. Arch Esp Urol (1998) 0.75
[Current status of neurostimulation and neuromodulation for vesicourethral dysfunction]. Arch Esp Urol (1997) 0.75
[Genito-urinary tuberculosis in acquired immunodeficiency syndrome]. Actas Urol Esp (1989) 0.75
[The problem of the false negative (superscan) in the isotopic diagnosis of prostatic neoplasms with dissemination to the bone]. Arch Esp Urol (1984) 0.75
[Differences in survival of patients with bladder cancer depending on depth of muscle infiltration]. Actas Urol Esp (2001) 0.75
[Effect of povidone-iodine in the prevention of surgical wound infection in urology]. Actas Urol Esp (1982) 0.75
[Uretero-iliac fistula]. Arch Esp Urol (1998) 0.75
[Effectiveness of transrectal ultrasonography in local staging of prostatic cancer]. Actas Urol Esp (1997) 0.75
[Laparoscopic bilateral nephrectomy of native kidney in kidney transplantation carriers]. Actas Urol Esp (1996) 0.75
[Penetrating renal injury]. Actas Urol Esp (1987) 0.75
[Obstructive uropathy in Gardner syndrome: a new case and an alternative therapeutic option]. Actas Urol Esp (1994) 0.75
[Management of pancreatic lesions in urologic surgery]. Actas Urol Esp (1992) 0.75
[Hemorrhagic prostatic cyst following ultrasound guided biopsy. A case report]. Arch Esp Urol (1999) 0.75
[Ultrasonographic and pathologic differences between non-palpable prostate cancer (T1c) and palpable lesions detected with rectal examination]. Actas Urol Esp (1997) 0.75
[Relationship between peripheral hypoechoic nodules of the prostatic gland and prostate cancer]. Actas Urol Esp (1996) 0.75
[Urethral sonography in the diagnosis and preoperative evaluation of urethral stenosis]. Actas Urol Esp (1992) 0.75
[Testicular torsion: experience with 28 cases]. Arch Esp Urol (1990) 0.75
[Endourologic treatment of ureteral ruptures in closed abdominal trauma]. Actas Urol Esp (1996) 0.75
[Upper urothelium tumor in patients treated with radical cystectomy for transitional carcinoma of the bladder]. Actas Urol Esp (1999) 0.75
[Embolism in renal artery]. Arch Esp Urol (1995) 0.75
[Gangrenous cystitis induced by giant bladder calculus]. Actas Urol Esp (1992) 0.75
[Nonpenetrating testicular injuries: usefulness of echography]. Actas Urol Esp (1987) 0.75
[Spontaneous bladder rupture with no apparent reason, a peculiar clinical occurrence]. Arch Esp Urol (1995) 0.75
[Renal adenocarcinoma with venous tumor extension to the right atrium: diagnostic and therapeutic considerations]. Arch Esp Urol (1996) 0.75
[Incidence of prostatic cancer in symptomatic patients with non-suspicious rectal palpation and PSA levels greater than 10 ng/ml]. Actas Urol Esp (1999) 0.75
[Incidence of high grade prostatic intraepithelial neoplasm in transrectal biopsy of the prostate]. Arch Esp Urol (2001) 0.75
[Cutaneous metastasis of a prostatic adenocarcinoma]. Arch Esp Urol (1988) 0.75
[Correlation of prostatic specific antigen, tumor grade, and local stage with bone scintigraphy in the staging of patients with prostatic cancer]. Arch Esp Urol (1997) 0.75
[The use of kidney grafts++ from donors of the same age or below 3 years (weight equal or below 15 Kg)]. Actas Urol Esp (1995) 0.75
[Functional and economic impact of the use of Wisconsin University conservation solution versus Eurocollins in relation to the period of cold ischemia in renal transplantation of cadaveric donor]. Actas Urol Esp (1995) 0.75
[Lymphocele after renal transplantation: therapeutic controversies in the age of laparoscopy]. Actas Urol Esp (1996) 0.75
[Usefulness of free PSA/total PSA ratio in the diagnosis of prostatic cancer in symptomatic patients with PSA levels ranging from 2.5 to 20 ng/ml]. Actas Urol Esp (2000) 0.75
[Ureteral triplicity: trifid ureter with ipsilateral ureterocele and renal dysplasia in an adult with testicular seminoma]. Actas Urol Esp (1991) 0.75
[Spontaneous rupture of the upper urinary tract: apropos of 2 cases]. Arch Esp Urol (1987) 0.75
[Bladder embryonal rhabdomyosarcoma in the adult]. Arch Esp Urol (1994) 0.75
[Non-penetrating renal injuries: apropos of 51 cases]. Actas Urol Esp (1987) 0.75
[Local recurrence after radical cystectomy for cancer of the bladder]. Actas Urol Esp (1998) 0.75
[Carcinoma of the penis: long-term follow-up]. Actas Urol Esp (1992) 0.75
[Substitution of inferior vena cava for Gore-Tex ring prosthesis: experimental study]. Arch Esp Urol (1992) 0.75
[Reliability of CT for determining lymphatic involvement in patients with prostate cancer]. Arch Esp Urol (1997) 0.75
[Transcatheter arterial embolization in the hemorrhagic complications of kidney trauma]. Arch Esp Urol (1993) 0.75
[Radical cystectomy in the treatment of cancer of the bladder]. Arch Esp Urol (2000) 0.75
[Scrotal condyloma acuminatum. Apropos of a case]. Arch Esp Urol (1989) 0.75
[Abdominal pain in patients undergoing radical cystectomy for bladder cancer]. Arch Esp Urol (1998) 0.75
[Yield of ultrasound-guided transrectal biopsy in the diagnosis of prostatic cancer in symptomatic patients]. Arch Esp Urol (1997) 0.75